Keywords: ribozyme, pharma, pharmacia, biotech, compound, development, deal

Ribozyme Pharma and Pharmacia Biotech in compound development deal

Article | 29 January 1996

Ribozyme Pharmaceuticals has joined with Pharmacia Biotech for the development of cost-effective methods of synthesizing amidites, the core molecular species ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in